FDA Press ReleasesOriginal article
FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Devices
RegulatoryNeutral
AI Analysis
Summary
The FDA issued a discussion paper seeking public feedback on regulatory considerations for generative AI-enabled medical devices, including risk assessment, premarket evaluation, and postmarket monitoring.
Outcome Details
FDA issued discussion paper on generative AI-enabled medical devices and seeking public feedback
Importance:3/10
Sentiment:
0.00
artificial_intelligencemedical_devicesregulatory_guidancegenerative_aiFDA
Related Companies
Read the original article
Published by FDA Press Releases on August 18, 2026 2:10 PM